Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05691465
Title	Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Recruitment	Recruiting
Gender	male
Phase	Phase II
Variant Requirements	Yes
Sponsors	National Cancer Institute (NCI)
Indications	prostate small cell carcinoma prostate adenocarcinoma prostate neuroendocrine neoplasm
Therapies	lutetium Lu 177 dotatate
Age Groups:	adult \| senior
Covered Countries	USA